AAA
ZYNE

Affinity Asset Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Affinity Asset Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,285
Closed -$62K – 81
2021
Q1 		$62K Hold
13,285
– – 0.02% 62
2020
Q4 		$44K Buy
+13,285
New +$44K 0.02% 56